INTRANIGRAL INJECTIONS OF SCH-23390 INHIBIT SKF-82958-INDUCED ROTATIONAL BEHAVIOR

被引:23
作者
YUREK, DM [1 ]
HIPKENS, SB [1 ]
机构
[1] UNIV KENTUCKY,COLL MED,DEPT ANAT & NEUROBIOL,LEXINGTON,KY 40536
关键词
SUBSTANTIA-NIGRA-PARS-RETICULATA; DOPAMINE; RODENT; D1; RECEPTOR; D2; APOMORPHINE; QUINPIROLE; STRIATONIGRAL PATHWAY;
D O I
10.1016/0006-8993(94)91748-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The selective Dl receptor antagonist, SCH 23390, was injected into the pars reticulata region of the lesioned substantia nigra at various concentrations (3.0, 1.5, 1.0, 0.6 or 0.3 mM) just before a s.c. injection of either the selective D1 agonist, SKF 82958; the selective D2 agonist, quinpirole; or the mixed D1-D2 receptor agonist, apomorphine. SCH 23390 pretreatment (1) had no significant effect on quinpirole rotational behavior, (2) attenuated apomorphine rotational behavior and (3) dose-dependently inhibited SKF 82958 rotational behavior with the highest SCH 23390 doses completely blocking SKF 82958 rotational behavior in some animals. These data provide further evidence that dopamine release in the midbrain may act as a neuromodulator of motor behavior, and that Dl receptors play a functional role in this process.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 10 条
[1]  
ALTAR CA, 1987, J NEUROSCI, V7, P213
[2]   [H-3]SCH-23390 BINDING TO D1 DOPAMINE-RECEPTORS IN THE BASAL GANGLIA OF THE CAT AND PRIMATE - DELINEATION OF STRIOSOMAL COMPARTMENTS AND PALLIDAL AND NIGRAL SUBDIVISIONS [J].
BESSON, MJ ;
GRAYBIEL, AM ;
NASTUK, MA .
NEUROSCIENCE, 1988, 26 (01) :101-119
[3]  
CZEKAJEWSKI J, 1983, PHARM BIOCH BEHAV, V19, P13
[4]   THE D1 DOPAMINE RECEPTOR IN THE RAT-BRAIN - QUANTITATIVE AUTORADIOGRAPHIC LOCALIZATION USING AN IODINATED LIGAND [J].
DAWSON, TM ;
BARONE, P ;
SIDHU, A ;
WAMSLEY, JK ;
CHASE, TN .
NEUROSCIENCE, 1988, 26 (01) :83-100
[5]   NIGRAL DOPAMINE TYPE-1 RECEPTORS ARE REDUCED IN HUNTINGTONS-DISEASE - A POSTMORTEM AUTORADIOGRAPHIC STUDY USING [H-3] SCH 23390 AND CORRELATION WITH [H-3] FORSKOLIN BINDING [J].
FILLOUX, F ;
WAGSTER, MV ;
FOLSTEIN, S ;
PRICE, DL ;
HEDREEN, JC ;
DAWSON, TM ;
WAMSLEY, JK .
EXPERIMENTAL NEUROLOGY, 1990, 110 (02) :219-227
[6]   AGONIST AND ANTAGONIST PROPERTIES OF BENZAZEPINE AND THIENOPYRIDINE DERIVATIVES AT THE D1 DOPAMINE RECEPTOR [J].
OBOYLE, KM ;
GAITANOPOULOS, DE ;
BRENNER, M ;
WADDINGTON, JL .
NEUROPHARMACOLOGY, 1989, 28 (04) :401-405
[7]   DOPAMINERGIC ACTIVITY OF SUBSTITUTED 6-CHLORO-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES [J].
PFEIFFER, FR ;
WILSON, JW ;
WEINSTOCK, J ;
KUO, GY ;
CHAMBERS, PA ;
HOLDEN, KG ;
HAHN, RA ;
WARDELL, JR ;
TOBIA, AJ ;
SETLER, PE ;
SARAU, HM .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (04) :352-358
[8]   H-3 SCH-23390 BINDING-SITES IN THE RAT SUBSTANTIA-NIGRA - EVIDENCE FOR A PRESYNAPTIC LOCALIZATION AND INNERVATION BY DOPAMINE [J].
PORCEDDU, ML ;
GIORGI, O ;
ONGINI, E ;
MELE, S ;
BIGGIO, G .
LIFE SCIENCES, 1986, 39 (04) :321-328
[9]  
ROBERTSON GS, 1989, J NEUROSCI, V9, P3326
[10]   INTRANIGRAL INJECTIONS OF SCH-23390 INHIBIT AMPHETAMINE-INDUCED ROTATIONAL BEHAVIOR [J].
YUREK, DM ;
HIPKENS, SB .
BRAIN RESEARCH, 1993, 623 (01) :56-64